Search
Displaying Results For:
Jan 12, 2026
COVID-19 Infection Linked to 49% Higher Risk of Autoimmune Disease
A new meta-analysis study combed through data from over 97 million individuals from population-based cohort studies and found that COVID-19 infection was linked to a 49% increased risk of developing new autoimmune diseases. This study compared individuals with and without COVID-19 and examined many parameters, including disease severity and vaccination status. Key Study Highlights Severe […]
- Autoimmune Diseases
- Infections
- Research Studies
Jan 05, 2026
COVID-19 Still Causes Major Illness and Deaths Study Finds
A new CDC-led study published in JAMA Internal Medicine estimates that COVID-19 continued to cause a substantial health burden in the United States from October 2022 through September 2024, even after the end of the public health emergency. Researchers estimate that COVID-19 led to approximately 43.6 million illnesses and 101,300 deaths in 2022–2023, and 33.0 million illnesses and 100,800 deaths in […]
- Infections
- Research Studies
Dec 16, 2025
Study Links Long COVID to Lasting Inflammation and Immune Exhaustion
A study published in Nature Immunology examined immune responses in people with long COVID and found evidence of sustained inflammation and immune exhaustion that can persist for months after initial infection. The researchers analyzed immune, transcriptomic, and proteomic data from 142 participants enrolled between 2020 and 2021, including individuals with long COVID, people who recovered fully, acutely […]
- Long COVID
- Research Studies
Dec 09, 2025
Long COVID, PCC, and PASC: Understanding the Terminology
Researchers and public health organizations use various terms to describe the persistent and emerging health problems that can follow SARS-CoV-2 infection. The most widely recognized term is long COVID, which originated with patients and has since been adopted in both clinical and research contexts, as it succinctly captures the experience of ongoing symptoms after acute COVID-19. […]
- Infections
- Long COVID
Dec 05, 2025
PCC Shows Clear Link to Autoimmune Disease
About Post COVID Condition (PCC) Post COVID Condition, often called Long Covid, refers to symptoms that begin during or after a SARS-CoV-2 infection and continue for at least two months. Symptoms cannot be explained by another diagnosis and may appear shortly after the initial infection or emerge later. PCC can affect multiple body systems, may […]
- Infections
- Long COVID
- Research Studies
- Rheumatoid Arthritis
- Sjögren disease
Dec 01, 2025
New Research Reveals Genetic Clues to Long COVID Subtypes
A new study in PLOS Computational Biology employs a large-scale “multi-omics” approach, integrating genetic data, gene-expression information, and network analysis to better understand why Long Covid affects people in so many different ways. Using this integrative framework, the researchers identified 32 “putative causal genes” that may help drive Long Covid. Nineteen of these genes had already been reported in […]
- Infections
- Long COVID
Nov 21, 2025
Autoimmune Markers Persist Two Years After COVID-19
A study published in an international medical research journal examined autoantibody expression in patients with Long Covid two years after hospital discharge from Covid-19 infection. Long Covid may partly result from immune alterations caused by SARS-CoV-2, including hyperinflammation, loss of immune tolerance, excessive NET (neutrophil extracellular trap) production, molecular mimicry, and immune dysregulation. According to […]
- Antibodies
- Infections
- Long COVID
- Research Studies
Nov 18, 2025
GLP-1 Drugs Enter Formal Testing for Long COVID Treatment
Scripps Research has launched a large, fully remote clinical trial to test whether the GLP-1/GIP medication tirzepatide (the active ingredient in Zepbound) can reduce long COVID symptoms. The LoCITT-T Trial (“locket”) is a randomized, placebo-controlled study enrolling 1,000 adults across the U.S., with no travel required. Early interest is high: more than 500 participants enrolled in the first […]
- Clinical Trials
- Long COVID
- Research Studies
- Treatments